Therapy
Health
Pharmaceutical

TherapeuticsMD

$4.91
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.08 (-1.60%) Today
-$0.02 (-0.41%) After Hours

Why Robinhood?

You can buy or sell TherapeuticsMD and other stocks, options, ETFs, and crypto commission-free!

About

TherapeuticsMD, Inc. operates as a healthcare company, which focuses on developing and commercializing products for women. Its technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. Read More The firm also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.

Employees
241
Headquarters
Boca Raton, Florida
Founded
1907
Market Cap
1.20B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
2.95M
High Today
$5.07
Low Today
$4.89
Open Price
$5.03
Volume
1.33M
52 Week High
$7.66
52 Week Low
$3.51

Collections

Therapy
Health
Pharmaceutical
Healthcare
Manufacturing
Technology
US
North America

News

Simply Wall StMar 18

Introducing TherapeuticsMD (NASDAQ:TXMD), The Stock That Dropped 17% In The Last Five Years

TherapeuticsMD, Inc. (NASDAQ:TXMD) shareholders will doubtless be very grateful to see the share price up 51% in the last quarter. But if you look at the last five years the returns have not been good. In fact, the share price is down 17%, which falls well short of the return you could get by buying an index fund. View our latest analysis for TherapeuticsMD TherapeuticsMD isn’t a profitable company, so it is unlikely we’ll see a strong correlation between its share price and its earnings per share (EPS). ...

603
BusinessWireMar 8

TherapeuticsMD Announces Oral Presentations on BIJUVA and ANNOVERA, and Poster Presentations Related to Menopause Symptoms and Treatments at 2019 ISSWSH/ISSM Joint Meeting

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today announced the schedule of oral presentations on clinical data for BIJUVATM (estradiol and progesterone capsules, 1 mg/100 mg) and ANNOVERATM (segesterone acetate/ethinyl estradiol vaginal system), and poster presentations related to menopause symptoms and treatments, at the International Society for the Study of Women’s Sexual Health (ISSWSH) and the International Society of Sexua...

388
Simply Wall StFeb 22

Is TherapeuticsMD, Inc.’s (NASDAQ:TXMD) Balance Sheet A Threat To Its Future?

Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! Investors are always looking for growth in small-cap stocks like TherapeuticsMD, Inc. (NASDAQ:TXMD), with a market cap of US$1.3b. However, an important fact which most ignore is: how financially healthy is the business? Companies operating in the Pharmaceuticals industry, especially ones that are currently loss-making, are more likely to be higher risk. So, understanding the company’s financial...

1

Earnings

-$0.21
-$0.16
-$0.12
-$0.07
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 2, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.